Mike Kuranda
Impact in
-
- Antibiotic Resistance in Bacteria
-
- Microbial Natural Products and Biosynthesis
Papers in
-
- Ubiquitin and proteasome pathways 2
- Melanoma and MAPK Pathways 2
- DNA Repair Mechanisms 1
- Glycosylation and Glycoproteins Research 1
- Mitochondrial Function and Pathology 1
-
- Computational Drug Discovery Methods 2
- Co-authors
- Zhi‐Dong Jiang (2 shared papers)David M. Rothstein (2 shared papers)Maureen T. DeCenzo (2 shared papers)Peter G. Smith (1 shared paper)Katherine Cosmopoulos (1 shared paper)Greg Hather (1 shared paper)Ray Liu (1 shared paper)Jonathan L. Blank (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (3 papers)The Journal of Antibiotics (2 papers)Analytical Biochemistry (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Mike Kuranda
7 papers receiving 104 citations
Peers
Comparison fields: 5 of 37
- Molecular Medicine 19
- Pharmacology 22
- Oncology 28
- Molecular Biology 73
- Microbiology 5
Countries citing papers authored by Mike Kuranda
This map shows the geographic impact of Mike Kuranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Kuranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Kuranda more than expected).
Fields of papers citing papers by Mike Kuranda
This network shows the impact of papers produced by Mike Kuranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Kuranda. The network helps show where Mike Kuranda may publish in the future.
Co-authors
The 25 scholars most cited alongside Mike Kuranda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 45 | |
| 2 | 1998 | 30 | |
| 3 | 2002 | 21 | |
| 4 | 2010 | 10 | |
| 5 | 2013 | 1 | |
| 6 | 2013 | 1 | |
| 7 | 2015 | 1 |
About Mike Kuranda
Mike Kuranda is a scholar working on Molecular Biology, Computational Theory and Mathematics, Organic Chemistry, Pharmacology and Pathology and Forensic Medicine, having authored 7 papers that have together received 109 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (2 papers), Melanoma and MAPK Pathways (2 papers), Computational Drug Discovery Methods (2 papers), Cancer Mechanisms and Therapy (1 paper), DNA Repair Mechanisms (1 paper), Glycosylation and Glycoproteins Research (1 paper), Mitochondrial Function and Pathology (1 paper) and Microfluidic and Bio-sensing Technologies (1 paper). The work is most often cited by research in Molecular Medicine (19 citations), Pharmacology (22 citations), Oncology (28 citations), Molecular Biology (73 citations) and Microbiology (5 citations). Mike Kuranda has collaborated with scholars based in United States and Japan. Frequent co-authors include Zhi‐Dong Jiang, David M. Rothstein, Maureen T. DeCenzo, Peter G. Smith, Katherine Cosmopoulos, Greg Hather, Ray Liu, Jonathan L. Blank, Colleen A. McNaney and Michael P. Thomas. Their work appears in journals such as Molecular Cancer Therapeutics, The Journal of Antibiotics, Analytical Biochemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.